Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Research Unit for Non-Coding RNAs and Genome Editing, Medical University of Graz, Graz, Austria.
Clin Cancer Res. 2017 Sep 1;23(17):5255-5266. doi: 10.1158/1078-0432.CCR-17-0023. Epub 2017 May 22.
miR-196b-5p has been previously implicated in malignant transformation; however, its role in colorectal cancer has not been fully explored. In this study, we examine the clinical and biological relevance of miR-196b-5p, and the molecular pathways regulated by miR-196b-5p in colorectal cancer. miR-196b-5p expression was quantitated by qRT-PCR in 2 independent cohorts composed of 292 patients with colorectal cancer in total, to explore its biomarker potential. Transient and stable gain- and loss-of-function experiments were conducted in a panel of colorectal cancer cell lines and mice, to evaluate the impact of miR-196b-5p on proliferation, chemosensitivity, migration/invasion, and metastases formation and The molecular pathways influenced by miR-196b-5p were characterized using whole transcriptome profiling, target prediction tools, luciferase interaction assays, and phenocopy/rescue gene knockdown experiments. Low miR-196b-5p expression was significantly associated with metastases and poor outcomes in 2 independent colorectal cancer patient cohorts ( < 0.05, log-rank test). miR-196b-5p inhibition led to significantly increased colorectal cancer cell migration/invasion and metastases formation in mice, whereas ectopic overexpression showed the opposite phenotype. Molecular profiling and target confirmation identified an interaction between miR-196b-5p and and which in turn regulated colorectal cancer cell migration. The association of low levels of miR-196b-5p and poor prognosis in patients with colorectal cancer can be explained by its influence on cancer cell migration and metastases formation. miR-196b-5p has an impact on colorectal cancer progression pathways through direct interaction with genes involved in cancer cell migration. .
miR-196b-5p 先前被认为与恶性转化有关;然而,其在结直肠癌中的作用尚未得到充分探索。在这项研究中,我们研究了 miR-196b-5p 的临床和生物学相关性,以及 miR-196b-5p 在结直肠癌中调节的分子途径。通过 qRT-PCR 在由 292 例结直肠癌患者组成的 2 个独立队列中定量检测 miR-196b-5p 的表达,以探索其作为生物标志物的潜力。在一系列结直肠癌细胞系和小鼠中进行了瞬时和稳定的增益和缺失功能实验,以评估 miR-196b-5p 对增殖、化疗敏感性、迁移/侵袭和转移形成的影响,并使用全转录组谱分析、靶标预测工具、荧光素酶相互作用测定和表型/挽救基因敲低实验来表征受 miR-196b-5p 影响的分子途径。低 miR-196b-5p 表达与 2 个独立的结直肠癌患者队列中的转移和不良结局显著相关(<0.05,对数秩检验)。miR-196b-5p 抑制导致小鼠中结直肠癌细胞迁移/侵袭和转移形成显著增加,而异位过表达则表现出相反的表型。分子谱分析和靶标确认表明 miR-196b-5p 与之间存在相互作用,进而调节结直肠癌细胞迁移。miR-196b-5p 水平低与结直肠癌患者预后不良之间的关联可以用其对癌细胞迁移和转移形成的影响来解释。miR-196b-5p 通过与参与癌细胞迁移的基因直接相互作用,对结直肠癌进展途径产生影响。